A randomized, double-blind, placebo-controlled trial for prevention of oxalipatin-induced peripheral neuropathy symptoms with pregabalin in patients with advanced colorectal cancer.

Meinolf Karthaus,Chris Karapetis,M. P. Brown,N. Pavlakis,T. Trarbach,N. Marschner,H. A. Duerk,C. Barone,M Luigi

A randomized, double-blind, placebo-controlled trial for prevention of oxalipatin-induced peripheral neuropathy symptoms with pregabalin in patients with advanced colorectal cancer.

2010

Meinolf Karthaus
Chris Karapetis
M. P. Brown
N. Pavlakis
T. Trarbach
N. Marschner
H. A. Duerk
C. Barone
M Luigi

e19573 Background: Sensorial peripheral neuropathy (PNP) is a major limitation for pts receiving oxaliplatin based ctx for CRC. Pregabalin is widely used for treatment of oxaliplatin induced PNP. W...

Keywords:

Physical therapy
Colorectal cancer
Peripheral neuropathy
Pregabalin
Medicine
Diabetes mellitus
Placebo-controlled study
Oxaliplatin
in patient
double blind
advanced colorectal cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations